GO CAPITAL
VC Fund
Rennes, France
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
- Total investments:
- 139
- Last investment:
- Lead investor:
- 39%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries GO CAPITAL invests in
Stages GO CAPITAL invests in
Countries GO CAPITAL invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $549k–$6.3M
- Series A
- $2.1M–$13M
Investment Focus
Industry
- Biotechnology 23 (17%)
- Software 22 (16%)
- Health Care 19 (14%)
- Manufacturing 13 (9%)
- Medical Device 12 (9%)
Stage
- Seed 35 (25%)
- Funding Round 30 (22%)
- Series A 27 (19%)
- Venture - Series Unknown 12 (9%)
- Series B 9 (6%)
Country
- France 96 (69%)
- Canada 2 (1%)
- Israel 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aude Kermarrec
Administration
|
Administration | Total investments: 0 | Find email | |
Frederic Le Brun
Partner
|
Partner | Total investments: 10 | Find email | |
Hervé BACHELOT LALLIER
Associate Investment Director
|
Associate Investment Director | Total investments: 3 | Find email | |
Jerome Gueret
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
Leila Nicolas
Investment Director
|
Investment Director | Total investments: 8 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Axomove
|
Axomove specializes in the prescription of video-based physical exercises. The company's movement knowledge is used by health professionals to improve remote monitoring of their patients and to avoid Musculoskeletal Disorders (MSDs) at work. | $4.7M / Series A / Apr 22, 2026 | |
Lifeaz
|
Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter defibrillators. | $15.4M / Seed / Feb 12, 2026 | |
BrightHeart
|
BrightHeart is a medical technology startup that is developing artificial intelligence software to help diagnose congenital heart abnormalities in foetuses. | $12.8M / Series A / Jan 08, 2026 | |
Alkion BioInnovations
|
Alkion BioInnovations was created in March 2017 in order to develop disruptive cannabinoid & pharmaceutical API production using large scale plant tissue production. The team works also on a new sugar replacement: a novel plant-based high intensive protein sweetener. The company won many R&D grants: I-lab, I-Nov, Plan de Relance & EICPhase I; and other prize: La Fabrique Aviva, Netva, Wilco, IPA4SME... | $5.1M / Seed / Nov 21, 2025 | |
Turbotech
|
TURBOTECH is a French start-up that develops on-board electric generation solutions for hybrid-electric aircrafts.Our solution consists of a very light and compact 55 kW turbo-generator in which a micro-turbine directly drives a high speed generator. This device produces electricity from virtually any fuel source (biofuel, hydrogen, Jet-A1,diesel, gasoline, etc...). All the while, maintaining a very high efficiency thanks to a heat exchanger that recovers -usually wasted- exhaust heat energy.TURBOTECH also develops a small 100 hp Turboprop dedicated to light aircrafts (135 hp for helicopters). It is equipped with the same heat exchanger as the turbogenerator, for a fuel consumption equivalent to best-in-class piston engines while being much lighter, quieter and more reliable. | $9.9M / Series A / Jun 25, 2025 | |
Expliseat
|
Expliseat combines innovation and manufacturing performance in the lightest aircraft seat in the world: the Titanium Seat. At just 4 kg, this seat reduces fuel consumption considerably, resulting in savings of up to $500,000 per plane per year. And with 10 patents, the Titanium Seat also provides passengers with greater comfort and 2 inches moreroom, thanks to its unique ergonomic design. | $41.8M / Jun 12, 2025 | |
Reelevant
|
Only 1 out of 10 people interact with marketing messages. Content is the bottleneck of personalization, not data. Personalization doesn't work because data are used to create targeted campaigns. Data must be used to create content because content creates interactions and drive conversion.Why: create content for people, not for campaigns(visual is the key to emotions) How: on-demand, when the user request, at the opening/reading/exposure (Pull content vs Push marketing) What: end-to-end widgets solutions like Live content, Individualization, Content Automation, Optimization, etc.Our visual content platform accelerates revenue, creates content based on any data (behavioral, contextual, etc.) created on the fly at the moment of exposure (on any channel (email, web, push notifications, in-app messages, etc.). We take advantage of existing data sources, nothing to create, we supercharge your marketing stack. Our data-driven Content Engine translates data from any source into on-demand visual content in milliseconds for each people.We believe in a new way of thinking about messages by shifting the paradigm of push marketing to transform any data into on-demand visual content. One unique content is created for each people on the fly at the moment people decide to read them (pull content), instead of when marketers decide to create them (push marketing).People are not data points, people don't buy products, they buy emotions. On-demand visual content is the new game! | $6.8M / Series A / Apr 29, 2025 | |
Moea
|
Moea is a company which uses bio-materials from fruits and plants to create low-carbon and vegan sneakers | $2.4M / Seed / Feb 27, 2025 | |
BiOceanOr
|
BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system. | $2.1M / Series A / Feb 25, 2025 | |
Sirius NeoSight
|
Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it. | $4.6M / Seed / Feb 04, 2025 | |
| See all 139 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does GO CAPITAL invest in?
GO CAPITAL invests primarily in Biotechnology, Software and Health Care startups, most often at Seed and Funding Round stage. Most of the 139 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is GO CAPITAL's check size?
GO CAPITAL typically joins rounds of $549k–$6.3M at Seed and $2.1M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds GO CAPITAL participates in.
How do I contact GO CAPITAL?
Public channels for GO CAPITAL include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at GO CAPITAL?
The team at GO CAPITAL includes Aude Kermarrec (Administration), Frederic Le Brun (Partner) and Hervé BACHELOT LALLIER (Associate Investment Director), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
